[{"address1": "Tower B, Vertical Business Suite", "address2": "Unit 02, Level 10 Bangsar South 8 Jalan Kerinchi", "city": "Kuala Lumpur", "zip": "59200", "country": "Malaysia", "phone": "60 1 2212 6512", "website": "https://www.bionexusgenelab.com", "industry": "Specialty Chemicals", "industryKey": "specialty-chemicals", "industryDisp": "Specialty Chemicals", "sector": "Basic Materials", "sectorKey": "basic-materials", "sectorDisp": "Basic Materials", "longBusinessSummary": "BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.", "fullTimeEmployees": 27, "companyOfficers": [{"maxAge": 1, "name": "Mr. Su-Leng  Tan", "age": 40, "title": "Chief Operating Officer", "yearBorn": 1983, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kwan Wah Chan", "title": "Marketing Manager", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Too Kam  Tham", "title": "Managing Director", "exercisedValue": 0, "unexercisedValue": 0}], "maxAge": 86400, "priceHint": 4, "previousClose": 0.8202, "open": 0.8, "dayLow": 0.76, "dayHigh": 0.8202, "regularMarketPreviousClose": 0.8202, "regularMarketOpen": 0.8, "regularMarketDayLow": 0.76, "regularMarketDayHigh": 0.8202, "beta": 1.907, "volume": 120713, "regularMarketVolume": 120713, "averageVolume": 1566390, "averageVolume10days": 628880, "averageDailyVolume10Day": 628880, "bid": 0.7701, "ask": 0.774, "bidSize": 900, "askSize": 1000, "marketCap": 13725288, "fiftyTwoWeekLow": 0.08, "fiftyTwoWeekHigh": 9.49, "priceToSalesTrailing12Months": 1.3277422, "fiftyDayAverage": 0.61778, "twoHundredDayAverage": 0.82487, "currency": "USD", "enterpriseValue": 9044730, "profitMargins": -0.29925, "floatShares": 10005021, "sharesOutstanding": 17792700, "sharesShort": 922176, "sharesShortPriorMonth": 21595, "sharesShortPreviousMonthDate": 1705017600, "dateShortInterest": 1707955200, "sharesPercentSharesOut": 0.051799998, "heldPercentInsiders": 0.63498, "heldPercentInstitutions": 0.0058999998, "shortRatio": 0.25, "shortPercentOfFloat": 0.062800005, "impliedSharesOutstanding": 17792700, "bookValue": 0.544, "priceToBook": 1.4180145, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -3093429, "trailingEps": -0.27, "enterpriseToRevenue": 0.875, "enterpriseToEbitda": -4.032, "52WeekChange": 0.60784316, "SandP52WeekChange": 0.30279303, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "BGLC", "underlyingSymbol": "BGLC", "shortName": "BioNexus Gene Lab Corp", "longName": "BioNexus Gene Lab Corp.", "firstTradeDateEpochUtc": 1610116200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "41fa38c7-39a9-3634-832e-8b50e40e0c35", "messageBoardId": "finmb_600164494", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.7714, "recommendationKey": "none", "totalCash": 6146883, "totalCashPerShare": 0.348, "ebitda": -2243079, "totalDebt": 138764, "quickRatio": 4.356, "currentRatio": 5.03, "totalRevenue": 10337314, "debtToEquity": 1.432, "revenuePerShare": 0.581, "returnOnAssets": -0.15126, "returnOnEquity": -0.38401002, "freeCashflow": 1184844, "operatingCashflow": -570741, "revenueGrowth": -0.008, "grossMargins": 0.13564, "ebitdaMargins": -0.21699, "operatingMargins": -0.98973, "financialCurrency": "USD", "trailingPegRatio": null}]